SWOG clinical trial number
SWOG-7430
5-Fluorouracil and Adriamycin in the Treatment of Incurable Hepatoma
Closed
Phase
II
Abbreviated Title
5-Fluorouracil and Adriamycin in the Treatment of Incurable Hepatoma
Activated
11/05/1974
Closed
06/11/1976
Research committees
Gastrointestinal Cancer
Publication Information Expand/Collapse
1977
Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
1976
5-fluorouracil and adriamycin therapy for hepatoma.
Other Clinical Trials
SWOG Clinical Trial Number
S2001
Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects
Research Committee(s)
Gastrointestinal Cancer
Activated
12/04/2020
Accrual
0%
Open
Phase
II
SWOG Clinical Trial Number
CTSU/A021806
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
07/01/2020
Open
SWOG Clinical Trial Number
S1922
Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
12/16/2019
Accrual
9%
Open
Phase
II